Free Trial
ASX:CUV

Clinuvel Pharmaceuticals (CUV) Stock Price, News & Analysis

Clinuvel Pharmaceuticals logo

About Clinuvel Pharmaceuticals Stock (ASX:CUV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
124,193 shs
Average Volume
N/A
Market Capitalization
A$563.18 million
P/E Ratio
15.95
Dividend Yield
0.44%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CUV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clinuvel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CUV Stock News Headlines

Undervalued ASX biotech
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Clinuvel Pharmaceuticals Stock Price History
High Growth Tech Stocks In Australia For March 2025
See More Headlines

CUV Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Clinuvel Pharmaceuticals investors own include Cochlear (COH), CSL (CSL), ResMed (RMD), ARB (ARB), Accent Group (AX1), Corporate Travel Management (CTD) and Mineral Resources (MIN).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:CUV
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$0.70
Trailing P/E Ratio
15.95
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
A$35.64 million
Net Margins
40.67%
Pretax Margin
N/A
Return on Equity
18.67%
Return on Assets
14.29%

Debt

Debt-to-Equity Ratio
0.43
Current Ratio
8.81
Quick Ratio
10.03

Sales & Book Value

Annual Sales
A$88.18 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
19.36
Book Value
A$4.02 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
50,060,000
Free Float
N/A
Market Cap
A$563.18 million
Optionable
Not Optionable
Beta
0.92
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (ASX:CUV) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners